Uganda launches HPV vaccine program; Two in U.K. prove rogue MMR strain rendered them deaf;

> In Uganda, a nationwide program has been launched to vaccinate girls against human papillomavirus (HPV), the precursor to cervical cancer. News

> A study examining HIV vaccine research over the past 5 years shows that Canada ranks first per capita in the number of articles published, compared with other leading nations taking part in research, like the U.S. Overall, Canada ranked fourth in the number of scholarly articles published on the topic. Article

> Two individuals in the U.K. proved to the country's Vaccine Damage Payments Unit that a rogue strain of the MMR vaccine left them deaf after receiving it between 1988 and 1992. Story

> With reports of the West Nile virus across 48 states and no vaccine in the foreseeable future, scientists from the University of Alabama at Birmingham urge individuals to be diligent in using mosquito repellant. Release

> Abbott ($ABT) and Astellas Pharma announced that they will collaborate on a Phase III clinical trial to test ASP0113, a candidate vaccine to prevent cytomegalovirus from occurring in organ transplant recipients. Release

Suggested Articles

Daiichi Sankyo says it still unable to fulfill a government mandate to be able to produce enough H5N1 flu vaccine to fight an epidemic in Japan.

GSK’s Shingrix has continuously impressed industry watchers with its growth, and the company just added another large market to its list: China.

WuXi Biologics says it will build a dedicated facility to manufacture a commercial vaccine product for a client in a $3 billion contract.